BUB1 and Lipedema: As transcriptional profiling has found BUB1 to be an essential target regulating cellular proliferation in lipedema ADSCs, researchers have used a CRISPR/Cas-9 lentiviral system to knock down BUB1, which decreases the proliferation of lipedema ADSCs [24].